Cargando…
Targeted Therapies in Rare Brain Tumours
Rare central nervous system (CNS) tumours represent a unique challenge. Given the difficulty of conducting dedicated clinical trials, there is a lack of therapies for these tumours supported by high quality evidence, and knowledge regarding the impact of standard treatments (i.e., surgery, radiother...
Autores principales: | Bruno, Francesco, Pellerino, Alessia, Bertero, Luca, Soffietti, Riccardo, Rudà, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348084/ https://www.ncbi.nlm.nih.gov/pubmed/34360713 http://dx.doi.org/10.3390/ijms22157949 |
Ejemplares similares
-
Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments
por: Pellerino, Alessia, et al.
Publicado: (2018) -
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?
por: Pellerino, Alessia, et al.
Publicado: (2022) -
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
por: Pellerino, Alessia, et al.
Publicado: (2023) -
Neurotoxicity from Old and New Radiation Treatments for Brain Tumors
por: Soffietti, Riccardo, et al.
Publicado: (2023) -
Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance
por: Mo, Francesca, et al.
Publicado: (2021)